Basic Information
| LncRNA/CircRNA Name | LINC00520 |
| Synonyms | NA |
| Region | GRCh38_14:55781135-55796688 |
| Ensemble | ENSG00000258791 |
| Refseq | NR_026796 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | nasopharyngeal cancer |
| ICD-0-3 | C11 |
| Methods | qPCR |
| Sample | NPC tissues and cells |
| Expression Pattern | up-regulated |
| Function Description | Results indicated that LINC00520 was significantly increasing in NPC tissues and cells in comparison to their corresponding controls. |
| Pubmed ID | 30898716 |
| Year | 2019 |
| Title | Long non-coding RNA 520 is a negative prognostic biomarker and exhibits pro-oncogenic function in nasopharyngeal carcinoma carcinogenesis through regulation of miR-26b-3p/USP39 axis. |
External Links
| Links for LINC00520 | GenBank HGNC NONCODE |
| Links for nasopharyngeal cancer | OMIM COSMIC |